These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 35904579)

  • 21. Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder.
    Staben J; Koch M; Reid K; Muckerheide J; Gilman L; McGuinness F; Kiesser S; Oswald IWH; Koby KA; Martin TJ; Kaplan JS
    Front Neurosci; 2023; 17():1185737. PubMed ID: 37397463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.
    Mostafavi M; Gaitanis J
    Semin Pediatr Neurol; 2020 Oct; 35():100833. PubMed ID: 32892960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: randomized, double-blind, and placebo-controlled clinical trial.
    Silva EAD; Medeiros WMB; Santos JPMD; Sousa JMM; Costa FBD; Pontes KM; Borges TC; Espínola C; Andrade E Silva AH; Nunes ELG; Alves NT; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2024; 46():e20210396. PubMed ID: 35617670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
    Loss CM; Teodoro L; Rodrigues GD; Moreira LR; Peres FF; Zuardi AW; Crippa JA; Hallak JEC; Abílio VC
    Front Pharmacol; 2020; 11():635763. PubMed ID: 33613289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aripiprazole for treating irritability associated with autism spectrum disorders.
    Bartram LA; Lozano J; Coury DL
    Expert Opin Pharmacother; 2019 Aug; 20(12):1421-1427. PubMed ID: 31180743
    [No Abstract]   [Full Text] [Related]  

  • 26. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story.
    Carbone E; Manduca A; Cacchione C; Vicari S; Trezza V
    Neurosci Biobehav Rev; 2021 Feb; 121():128-143. PubMed ID: 33358985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autism and associated disorders: cannabis as a potential therapy.
    Babayeva M; Assefa H; Basu P; Loewy Z
    Front Biosci (Elite Ed); 2022 Jan; 14(1):1. PubMed ID: 35320905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Advances in the Pharmacological Management of Behavioral Disturbances Associated with Autism Spectrum Disorder in Children and Adolescents.
    Lamy M; Pedapati EV; Dominick KL; Wink LK; Erickson CA
    Paediatr Drugs; 2020 Oct; 22(5):473-483. PubMed ID: 32686015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
    Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Román V; Adham N; Foley AG; Hanratty L; Farkas B; Lendvai B; Kiss B
    Psychopharmacology (Berl); 2021 Sep; 238(9):2381-2392. PubMed ID: 34264367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol as a Potential Treatment for Anxiety Disorders.
    Blessing EM; Steenkamp MM; Manzanares J; Marmar CR
    Neurotherapeutics; 2015 Oct; 12(4):825-36. PubMed ID: 26341731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder.
    Poleg S; Kourieh E; Ruban A; Shapira G; Shomron N; Barak B; Offen D
    Transl Psychiatry; 2021 Oct; 11(1):524. PubMed ID: 34645786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
    Silva EAD; Medeiros WMB; Torro N; Sousa JMM; Almeida IBCM; Costa FBD; Pontes KM; Nunes ELG; Rosa MDD; Albuquerque KLGD
    Trends Psychiatry Psychother; 2022 Jun; 44():e20200149. PubMed ID: 34043900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Autism Spectrum Disorder in Children and Adolescents.
    DeFilippis M; Wagner KD
    Psychopharmacol Bull; 2016 Aug; 46(2):18-41. PubMed ID: 27738378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mood Stabilizers in Children and Adolescents With Autism Spectrum Disorders.
    Canitano R
    Clin Neuropharmacol; 2015; 38(5):177-82. PubMed ID: 26366961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures.
    Politte LC; Scahill L; Figueroa J; McCracken JT; King B; McDougle CJ
    Neuropsychopharmacology; 2018 Jul; 43(8):1772-1778. PubMed ID: 29540864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of CBD-Enriched
    Fleury-Teixeira P; Caixeta FV; Ramires da Silva LC; Brasil-Neto JP; Malcher-Lopes R
    Front Neurol; 2019; 10():1145. PubMed ID: 31736860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
    Naguy A
    J Nerv Ment Dis; 2017 Sep; 205(9):738. PubMed ID: 28846573
    [No Abstract]   [Full Text] [Related]  

  • 40. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.